Sandstrom Per, Brooke-Smith Mark E, Thomas Anthony C, Grivell Marlene B, Saccone Gino T P, Toouli James, Svanvik Joar
Department of Biomedicine and Surgery, University Hospital of Linkoping, Linkoping, Sweden.
Pancreas. 2005 Jan;30(1):e10-5.
Inducible nitric oxide synthase (iNOS) activity is increased in experimental acute pancreatitis. The aim of this study was to evaluate treatment with the selective iNOS inhibitors AR-C (AR-C102222AA) and L-NIL (L-N6-(1-iminoethyl)-lysine) in experimental acute pancreatitis.
Acute pancreatitis was induced in anesthetized Australian possums by topical administration of carbachol on the sphincter of Oddi. AR-C treatment was 2 intravenous infusions (2.5 micromol/kg over 15 minutes) at 2 and 4 hours after acute pancreatitis induction. L-NIL treatment was an intraarterial infusion (1 mg/kg/h) from 2 hours after acute pancreatitis induction. At 8 hours, pancreatic tissue was harvested and inflammation assessed (histologic score). Blood samples were collected for plasma amylase, lipase, and amino acid levels. Blood pressure, central venous pressure, supplementary fluids, and urine output were monitored.
Treatment with AR-C or L-NIL reduced the plasma levels of amylase and the volume of supplementary fluids and improved the histological score (all P < 0.05). In animals with acute pancreatitis, plasma arginine levels were reduced (P < 0.05), while citrulline and ornithine levels increased (P < 0.05), consistent with increased nitric oxide production. Treatment with AR-C ameliorated the reduced arginine level.
Treatment with AR-C or L-NIL, commencing 2 hours after the induction of acute pancreatitis, has significant and beneficial effects in experimental acute pancreatitis in Australian possums.
实验性急性胰腺炎中诱导型一氧化氮合酶(iNOS)活性增加。本研究旨在评估选择性iNOS抑制剂AR-C(AR-C102222AA)和L-NIL(L-N6-(1-亚氨基乙基)-赖氨酸)对实验性急性胰腺炎的治疗效果。
通过在麻醉的澳大利亚负鼠的Oddi括约肌局部给予卡巴胆碱诱导急性胰腺炎。AR-C治疗是在急性胰腺炎诱导后2小时和4小时进行2次静脉输注(2.5微摩尔/千克,持续15分钟)。L-NIL治疗是在急性胰腺炎诱导后2小时开始进行动脉内输注(1毫克/千克/小时)。8小时时,采集胰腺组织并评估炎症(组织学评分)。采集血样检测血浆淀粉酶、脂肪酶和氨基酸水平。监测血压、中心静脉压、补液量和尿量。
AR-C或L-NIL治疗降低了血浆淀粉酶水平和补液量,并改善了组织学评分(均P<0.05)。在急性胰腺炎动物中,血浆精氨酸水平降低(P<0.05),而瓜氨酸和鸟氨酸水平升高(P<0.05),这与一氧化氮生成增加一致。AR-C治疗改善了降低的精氨酸水平。
在急性胰腺炎诱导后2小时开始用AR-C或L-NIL治疗,对澳大利亚负鼠的实验性急性胰腺炎有显著的有益效果。